The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Survival benefit and clinical characteristics of patients with metastatic colorectal cancer (mCRC) receiving pulmonary metastasectomy.
 
Javier Soto Alsar
No Relationships to Disclose
 
Roberto Jiménez Rodríguez
No Relationships to Disclose
 
Marianela Bringas Beranek
No Relationships to Disclose
 
Natalia Gutiérrez Alonso
No Relationships to Disclose
 
Rocío Martín Lozano
No Relationships to Disclose
 
Irene Gonzalez Caraballo
No Relationships to Disclose
 
Sara Pérez Pérez
No Relationships to Disclose
 
Guillermo González Casaurrán
No Relationships to Disclose
 
Andrés Muñoz
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Pfizer; Celgene; Daiichi Sankyo; Incyte; LEO Pharma; Lilly; MSD Oncology; Roche; Sanofi; SERVIER
Speakers' Bureau - Bayer; Menarini; Rovi; SERVIER; STADA
Research Funding - Celgene; LEO Pharma; Rovi; Sanofi
Patents, Royalties, Other Intellectual Property - Risk assessment model in venous thromboembolism in cancer patients
Travel, Accommodations, Expenses - Amgen; Celgene; Merck Serono; Pfizer; Roche; SERVIER
 
Laura Ortega Morán
No Relationships to Disclose
 
Aitana Calvo
No Relationships to Disclose
 
Gabriela Torres Pérez-Solero
No Relationships to Disclose
 
Miguel Martin
Honoraria - Lilly; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; SEAGEN
Consulting or Advisory Role - AstraZeneca; Daiichi-Sankyo; Lilly; Novartis; Pfizer; Roche/Genentech
Speakers' Bureau - Lilly/ImClone; Lilly/ImClone; Pierre Fabre; Roche/Genentech
Research Funding - Novartis (Inst); Puma Biotechnology (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Daichii-Sankyo
Other Relationship - Novartis; Roche
 
Carlos María Simón Adiego
No Relationships to Disclose
 
Pilar Garcia-Alfonso
No Relationships to Disclose